BSE Live
Dec 05, 16:01Prev. Close
948.85
Open Price
947.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 05, 15:59Prev. Close
949.25
Open Price
945.00
Bid Price (Qty.)
933.60 (3)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Natco Pharma (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 60.86 | 53.42 | 54.55 | 39.79 | 27.22 | |
| Net CashFlow From Operating Activities | 70.43 | 33.16 | 29.71 | 38.48 | 32.37 | |
| Net Cash Used In Investing Activities | -53.59 | -51.46 | -43.04 | -33.28 | -24.38 | |
| Net Cash Used From Financing Activities | -32.90 | 18.46 | 9.16 | -8.39 | -27.04 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -16.06 | 0.17 | -4.16 | -3.19 | -19.05 | |
| Cash And Cash Equivalents Begin of Year | 18.39 | 19.93 | 24.09 | 27.28 | 46.33 | |
| Cash And Cash Equivalents End Of Year | 2.33 | 20.09 | 19.93 | 24.09 | 27.28 |
26.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
24.11.2025
Natco Pharma Standalone September 2025 Net Sales at Rs 1,264.30 crore, down 2.19% Y-o-Y
24.11.2025
24.11.2025
26.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
24.11.2025
Natco Pharma Standalone September 2025 Net Sales at Rs 1,264.30 crore, down 2.19% Y-o-Y
14.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
09.09.2025
Natco Pharma Standalone June 2025 Net Sales at Rs 1,192.70 crore, down 3.57% Y-o-Y